Long-term experience with the Sorin Bicarbon and Edwards Mira mechanical valve prostheses in the mitral position

被引:5
作者
Fukui T. [1 ]
Shibata T. [2 ]
Sasaki Y. [1 ]
Hirai H. [1 ]
Motoki M. [1 ]
Takahashi Y. [1 ]
Suehiro S. [1 ]
机构
[1] Department of Cardiovascular Surgery, Osaka City University, Graduate School of Medicine, Abeno-ku, Osaka 545-8585
[2] Department of Cardiovascular Surgery, Kansai Rosai Hospital, Hyogo
关键词
Heart valve disease; Mechanical valve; Mitral valve; Mitral valve replacement;
D O I
10.1007/s11748-006-0081-7
中图分类号
学科分类号
摘要
Objective. Sorin Bicarbon (SB) and Edwards Mira (EM) valves have an identical mechanical design but different sewing cuffs. The purpose of this retrospective study was to analyze the long-term clinical and echocardiographic outcomes after mitral valve replacement with these two valves in a combined population of patients. Methods. We retrospectively reviewed records of 73 patients who underwent mitral valve replacement using SB (n = 19) or EM (n = 54) valves. Preoperatively, 49 patients (68.1%) were in New York Heart Association (NYHA) functional class III or IV. Concomitant procedures were performed in 52 patients (71.2%). Early and late postoperative echocardiography was performed in 69 and 57 patients, respectively. Results. Operative mortality was 4.1%, and early morbidity was 9.6%. Overall patient survival at 9 years was 85.1% ± 4.8%. Actuarial freedom from valve-related death was 95.4% ± 2.6% at 9 years. As shown by Doppler echocardiography, the early and late mean transprosthetic pressure gradients were 3.4 ± 1.4mmHg and 3.8 ± 2.1mmHg, respectively. At the end of follow-up, 98.4% of survivors were in NYHA class I or II. Conclusion. The Sorin Bicarbon and Edwards Mira mechanical valves in the mitral position provide satisfactory long-term clinical and echocardiographic performance. © 2007 The Japanese Association for Thoracic Surgery.
引用
收藏
页码:91 / 97
页数:6
相关论文
共 25 条
[11]  
Kumano H., Suehiro S., Hattori K., Shibata T., Sasaki Y., Hosono M., Et al., Coagulofibrinolysis during heparin-coated cardiopulmonary bypass with reduced heparinization, Ann Thorac Surg, 68, pp. 1252-6, (1999)
[12]  
Ikuta T., Fujii H., Shibata T., Hattori K., Hirai H., Kumano H., Et al., A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy, Ann Thorac Surg, 77, pp. 1678-83, (2004)
[13]  
Edmunds Jr. L.H., Clark R.E., Cohn L.H., Grunkemeier G.L., Miller D.C., Weisel R.D., Guidelines for reporting morbidity and mortality after cardiac valvular operations, Ann Thorac Surg, 62, pp. 932-5, (1996)
[14]  
Fiore A.C., Barner H.B., Swartz M.T., McBride L.R., Labovitz A.J., Vaca K.J., Et al., Mitral valve replacement: Randomized trial of St. Jude and Medtronic Hall prostheses, Ann Thorac Surg, 66, pp. 707-12, (1998)
[15]  
Jamieson W.R., Miyagishima R.T., Grunkemeier G.L., Germann E., Henderson C., Fradet G.J., Et al., Bileaflet mechanical prostheses performance in mitral position, Eur J Cardiothorac Surg, 15, pp. 786-94, (1999)
[16]  
Stefanidis C., Nana A.M., De Canniere D., Antoine M., Jansens J.L., Huynh C.H., Et al., 10-year experience with the ATS mechanical valve in the mitral position, Ann Thorac Surg, 79, pp. 1934-8, (2005)
[17]  
Kang C.H., Ahn H., Kim K.H., Kim K.B., Long-term result of 1144 CarboMedics mechanical valve implantations, Ann Thorac Surg, 79, pp. 1939-44, (2005)
[18]  
Borman J.B., Brands W.G., Camilleri L., Cotrufo M., Daenen W., Gandjbakhch I., Et al., Bicarbon valve-European multicenter clinical evaluation, Eur J Cardiothorac Surg, 13, pp. 685-93, (1998)
[19]  
De Feo M., Renzulli A., Onorati F., Della Corte A., Dialetto G., Covino F.E., Et al., Initial clinical and hemodynamic experience with Edwards MIRA™ Mechanical Bileaflet Valve, J Cardiovasc Surg, 44, pp. 25-30, (2003)
[20]  
Driever R., Fuchs S., Meissner M., Schmitz E., Vetter H.O., The Edwards MIRA heart valve prosthesis: A 2-year study, J Card Surg, 19, pp. 226-31, (2004)